The estimated Net Worth of Robert B Shapiro is at least $607 Mille dollars as of 22 February 2023. Mr. Shapiro owns over 61,576 units of Precigen Inc stock worth over $293,651 and over the last 11 years he sold PGEN stock worth over $0. In addition, he makes $312,992 as Lead Independent Director at Precigen Inc.
Robert has made over 8 trades of the Precigen Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 61,576 units of PGEN stock worth $59,729 on 22 February 2023.
The largest trade he's ever made was exercising 62,189 units of Precigen Inc stock on 13 March 2021 worth over $60,323. On average, Robert trades about 6,063 units every 92 days since 2013. As of 22 February 2023 he still owns at least 302,733 units of Precigen Inc stock.
You can see the complete history of Mr. Shapiro stock trades at the bottom of the page.
Robert. B. Shapiro is an lead Independent Director of Intrexon Corporation. Mr. Shapiro has served as a Board member since November 2011. Mr. Shapiro is Chairman, Managing Director and Co-Founder of Sandbox Industries, a development firm that creates, launches, and manages new business concepts. Sandbox Industries also manages venture funds, including the BlueCross BlueShield Venture Partners funds and the Cultivan Sandbox Food & Agriculture Venture Funds. Mr. Shapiro has served as Managing Director of Sandbox Industries since its formation in 2004. He was formerly Chairman and Chief Executive Officer of Monsanto Company from 1995 to 2000. Upon the merger of Monsanto Company with Pharmacia & Upjohn, he served as Chairman of the newly formed Pharmacia Corporation. Previously, Mr. Shapiro was President and Chief Operating Officer of Monsanto Company from 1992 to 1995 and President of Monsanto Company’s Agriculture Group from 1990 to 1992, Chairman and Chief Executive Officer of The NutraSweet Company, a subsidiary of Monsanto Company, from 1985 to 1990 and President of the NutraSweet Group of G.D. Searle & Co., or Searle, from 1982 to 1985, where he previously served as Vice President and General Counsel. Before joining Searle, Mr. Shapiro was Vice President and General Counsel of General Instrument Corporation from 1972 to 1979. Prior to this, he practiced law in New York City; served in government as Special Assistant to the General Counsel and later to the Undersecretary of the U.S. Department of Transportation; and served as a professor of law at Northeastern University in Boston and the University of Wisconsin in Madison.
As the Lead Independent Director of Precigen Inc, the total compensation of Robert Shapiro at Precigen Inc is $312,992. There are 9 executives at Precigen Inc getting paid more, with Randal Kirk having the highest compensation of $2,067,620.
Robert Shapiro is 81, he's been the Lead Independent Director of Precigen Inc since 2011. There are no older and 18 younger executives at Precigen Inc.
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares e Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Precigen Inc executives and other stock owners filed with the SEC include: